Oral cancer detection kit
First-of-its kind oral cancer diagnosis test kit, which includes a dual test. This very simple test will diagnose oral cancer at a precancerous stage, thus preventing cancer from even happening. Dr Zahra Hussaini of C Test Medicals Pvt Ltd.
Cancer undoubtedly is a deadly disease and scientists round the world is yet to find an answer to it. Cancer as we all know is uncontrolled growth of cells inside the body. Old cells do not grow instead they grow in an abnormal way. Presently we see huge developments in the field of cancer treatment and if detected early can actually cure cancer. Newer treatment strategies like chemotherapy, immunotherapy, and cancer surgery have been in great use in order to tackle cancer and its effective management.
As per WHO, oral cancer is a major health problem worldwide. Its among the top 3 cancers that are prevalent. It is estimated that 1.7 million people will be affected by oral cancer by year 2035. Globally, one person dies every hour due to oral cancer. In India, oral cancer constitutes 12% of all cancer in men and 8% of all cancers in women. Every year, 3 lakh new cases of oral cancer is diagnosed in India.
In the latest development, Dr Zahra Hussaini from Nanavati hospital, Mumbai, who focused on oral cancer and its treatment, discovered something very new and unique. After 12 years of research and untiring work, she made world’s first swivel biopsy test for detection and prevention of cancer.
With her own designed kit, she can detect the cancer 6 years in advance. This means that no one will die of the deadly disease in the world, if awareness is spread about her discovery. She aims at reaching out to rural India, as 70% of total deaths occur there alone. To fulfill her dream of curing cancer, she launched her organization, C-TEST (Cancer Test), in presence of many Bollywood celebrities, including Javed Jaffrey.
Advantages of C TEST KIT
- Economical & uncomplicated test.
- Easy to do & completely painless.
- No anesthesia or suturing required.
- Dual test will increase the accuracy.
- Completely sterile with disposable tips.
- Easy packaging for transportation of biopsy samples.
- Reports can be obtained in 2 days.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
About Susan Hau
Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy. Hau's expertise lies in cancer cell biolo…
✓ Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.